TNP-2092
- Generic Name
- TNP-2092
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C65H81FN6O15
- CAS Number
- 922717-97-3
- Unique Ingredient Identifier
- W2P7EF7O6O
- Background
TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection).
- Associated Conditions
- -
- Associated Therapies
- -
TenNor Announces More than 300 Million RMB Financing to Support Development and ...
TenNor Therapeutics secures over 300 million RMB in Series E funding, with AMR Action Fund and Zhongshan Venture Capital, to develop rifasutenizol, a potential first new drug for Helicobacter pylori infection in 30 years, and TNP-2092 for medical device infections.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath